|
APEX2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.607000E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.775300E-03 |
| Normal-vs-Stage2 |
8.099900E-02 |
| Normal-vs-Stage3 |
1.915920E-03 |
| Normal-vs-Stage4 |
1.188190E-02 |
| Stage1-vs-Stage2 |
8.469200E-01 |
| Stage1-vs-Stage3 |
3.965200E-01 |
| Stage1-vs-Stage4 |
5.361400E-01 |
| Stage2-vs-Stage3 |
4.827400E-01 |
| Stage2-vs-Stage4 |
5.657600E-01 |
| Stage3-vs-Stage4 |
9.354000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.24460000000293E-05 |
| Normal-vs-AfricanAmerican |
1.817360E-03 |
| Normal-vs-Asian |
7.182700E-03 |
| Caucasian-vs-AfricanAmerican |
7.388000E-01 |
| Caucasian-vs-Asian |
6.372800E-01 |
| AfricanAmerican-vs-Asian |
5.571800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.074140E-02 |
| Normal-vs-Female |
3.161800E-04 |
| Male-vs-Female |
5.568000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.059200E-03 |
| Normal-vs-Age(41-60Yrs) |
2.284500E-03 |
| Normal-vs-Age(61-80Yrs) |
1.812070E-02 |
| Normal-vs-Age(81-100Yrs) |
3.765900E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.003200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.703000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.112000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.935600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.029810E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.837800E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.127600E-01 |
| Classical-VS-Follicular |
3.48379991521597E-10 |
| Classical-VS-Other |
2.054300E-02 |
| Classical-VS-Normal |
5.60739999988513E-07 |
| Tall-VS-Follicular |
8.45910000000227E-05 |
| Tall-VS-Other |
3.421700E-02 |
| Tall-VS-Normal |
1.516880E-03 |
| Follicular-VS-Other |
8.669800E-01 |
| Follicular-VS-Normal |
2.103000E-01 |
| Other-VS-Normal |
5.953000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.541900E-03 |
| Normal-vs-N1 |
6.831000E-01 |
| N0-vs-N1 |
1.485970E-01 |
|
|
